Mandating Exclusive Review of Individual Treatments (MERIT) Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Oct 4, 2022)
Mandating Exclusive Review of Individual Treatments (MERIT) Act
This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.
What just happenedOct 5, 2022
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseOct 4, 2022
- Oct 5, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 4, 2022IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Oct 4, 2022IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Oct 4, 2022IntroReferralIntro-H
Introduced in House
- Oct 4, 2022IntroReferral1000
Introduced in House